Key facts
- This page summarizes Michael J. Bourque's Form 4 filing for Inogen Inc (INGN).
- 10 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 03 Mar 2026, 16:57.
Michael J. Bourque - 27 Feb 2026 Form 4 Insider Report for Inogen Inc (INGN)
- Reporting relationship
- EVP, CFO & Treasurer
- Issuer ticker
- INGN
- Reported as of
- 27 Feb 2026
- Net transaction value
- -$155,135
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2026, 16:57:16 UTC
- Prior SEC filing
- 03 Sep 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mary Wright, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael J. Bourque filed Form 4 for Inogen Inc (INGN) on 03 Mar 2026.
Change
- Previous filing in this sequence was filed on 03 Sep 2025.
- Current net transaction value: -$155,135.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001638420
Primary reporting owner
Bourque Michael J.
- Relationship
- EVP, CFO & Treasurer
- Address
- C/O INOGEN, INC., 500 CUMMINGS CENTER, SUITE 2800, BEVERLY
- Signature
- /s/ Mary Wright, as Attorney-in-Fact
- Signature date
- 03 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INGN
transaction
Common Stock
Award
- Transaction value
- $5,331
- Shares
- +874
- Change %
- +1.8%
- Price
- $6.10
- Shares after
- 50,020
- Date
- 01 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
INGN
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +25,000
- Change %
- +50%
- Price
- $0.000000
- Shares after
- 75,020
- Date
- 01 Mar 2026
- Ownership
- Direct
INGN
transaction
Common Stock
Tax liability
- Transaction value
- $56,962
- Shares
- -9,338
- Change %
- -12%
- Price
- $6.10
- Shares after
- 65,682
- Date
- 01 Mar 2026
- Ownership
- Direct
- Footnotes
- F2
INGN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +28,875
- Change %
- +44%
- Price
- $0.000000
- Shares after
- 94,557
- Date
- 01 Mar 2026
- Ownership
- Direct
- Footnotes
- F3
INGN
transaction
Common Stock
Tax liability
- Transaction value
- $64,752
- Shares
- -10,615
- Change %
- -11%
- Price
- $6.10
- Shares after
- 83,942
- Date
- 01 Mar 2026
- Ownership
- Direct
- Footnotes
- F4
INGN
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +17,007
- Change %
- +20%
- Price
- $0.000000
- Shares after
- 100,949
- Date
- 01 Mar 2026
- Ownership
- Direct
INGN
transaction
Common Stock
Tax liability
- Transaction value
- $38,753
- Shares
- -6,353
- Change %
- -6.3%
- Price
- $6.10
- Shares after
- 94,596
- Date
- 01 Mar 2026
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INGN
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +39,000
- Change %
- Price
- $0.000000
- Shares after
- 39,000
- Date
- 27 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 39,000
- Exercise price
- Footnotes
- F5, F6
INGN
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -25,000
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 25,000
- Date
- 01 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- Footnotes
- F5, F7
INGN
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -17,007
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 34,013
- Date
- 01 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,007
- Exercise price
- Footnotes
- F5, F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 8 footnotes
Footnote F1
Shares acquired through the Company's 2014 Employee Stock Purchase Plan.
Footnote F2
The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026.
Footnote F3
The reported securities represent shares earned and vested on March 1, 2026 based on achievement of the financial performance conditions for the 2025 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on March 4, 2024.
Footnote F4
The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on March 4, 2024 and vested on March 1, 2026.
Footnote F5
Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
Footnote F6
Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.
Footnote F7
1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date.
Footnote F8
1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.